Literature DB >> 24585106

Infective endocarditis: therapeutic options and indications for surgery.

Aneil Malhotra1, Jenny Rayner, Timothy M Williams, Bernard Prendergast.   

Abstract

Infective endocarditis is a serious, life-threatening condition with mortality of 30% at one year. Established treatment is a combination of anti-microbial therapy and close interface between multiple specialist teams of cardiologists, microbiologists and cardiac surgeons to ensure availability of early surgery to those patients who require it. There are evidence-based established indications for surgery and a shifting body of evidence advocating earlier surgical intervention. The development of complications is often the driving cause of referral for surgical intervention. Here we discuss the management of infective endocarditis, considering both antimicrobial therapy and indications for surgery to treat this debilitating disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24585106     DOI: 10.1007/s11886-014-0464-9

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  53 in total

Review 1.  Brucella endocarditis: the role of combined medical and surgical treatment.

Authors:  F Jacobs; D Abramowicz; P Vereerstraeten; J L Le Clerc; F Zech; J P Thys
Journal:  Rev Infect Dis       Date:  1990 Sep-Oct

2.  Dramatic reduction in infective endocarditis-related mortality with a management-based approach.

Authors:  Elisabeth Botelho-Nevers; Franck Thuny; Jean Paul Casalta; Hervé Richet; Frédérique Gouriet; Frédéric Collart; Alberto Riberi; Gilbert Habib; Didier Raoult
Journal:  Arch Intern Med       Date:  2009-07-27

3.  Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

Authors:  P Tornos; B Almirante; S Mirabet; G Permanyer; A Pahissa; J Soler-Soler
Journal:  Arch Intern Med       Date:  1999-03-08

4.  Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke.

Authors:  Bruno Barsic; Stuart Dickerman; Vladimir Krajinovic; Paul Pappas; Javier Altclas; Giampiero Carosi; José H Casabé; Vivian H Chu; Francois Delahaye; Jameela Edathodu; Claudio Querido Fortes; Lars Olaison; Ana Pangercic; Mukesh Patel; Igor Rudez; Syahidah Syed Tamin; Josip Vincelj; Arnold S Bayer; Andrew Wang
Journal:  Clin Infect Dis       Date:  2012-10-16       Impact factor: 9.079

5.  Risk factors for "major" embolic events in hospitalized patients with infective endocarditis.

Authors:  Emanuele Durante Mangoni; Luigi E Adinolfi; Marie-Francoise Tripodi; Augusto Andreana; Michele Gambardella; Enrico Ragone; Davide F Precone; Riccardo Utili; Giuseppe Ruggiero
Journal:  Am Heart J       Date:  2003-08       Impact factor: 4.749

6.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

Review 7.  Role of echocardiography in the diagnosis and management of infective endocarditis.

Authors:  Sonia Jacob; Ann T Tong
Journal:  Curr Opin Cardiol       Date:  2002-09       Impact factor: 2.161

8.  Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study.

Authors:  Franck Thuny; Jean-François Avierinos; Christophe Tribouilloy; Roch Giorgi; Jean-Paul Casalta; Loïc Milandre; Amel Brahim; Georges Nadji; Alberto Riberi; Frédéric Collart; Sebastien Renard; Didier Raoult; Gilbert Habib
Journal:  Eur Heart J       Date:  2007-03-15       Impact factor: 29.983

9.  Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach.

Authors:  A Mügge; W G Daniel; G Frank; P R Lichtlen
Journal:  J Am Coll Cardiol       Date:  1989-09       Impact factor: 24.094

10.  Non-HACEK gram-negative bacillus endocarditis.

Authors:  Susan Morpeth; David Murdoch; Christopher H Cabell; Adolf W Karchmer; Paul Pappas; Donald Levine; Francisco Nacinovich; Pierre Tattevin; Núria Fernández-Hidalgo; Stuart Dickerman; Emilio Bouza; Ana del Río; Tatjana Lejko-Zupanc; Auristela de Oliveira Ramos; Diana Iarussi; John Klein; Catherine Chirouze; Roger Bedimo; G Ralph Corey; Vance G Fowler
Journal:  Ann Intern Med       Date:  2007-12-18       Impact factor: 25.391

View more
  5 in total

Review 1.  Cross-sectional imaging of aortic infections.

Authors:  D J Murphy; A R Keraliya; M D Agrawal; A Aghayev; M L Steigner
Journal:  Insights Imaging       Date:  2016-10-19

2.  The Superantigen Toxic Shock Syndrome Toxin 1 Alters Human Aortic Endothelial Cell Function.

Authors:  Katarina Kulhankova; Kyle J Kinney; Jessica M Stach; Françoise A Gourronc; Isabella M Grumbach; Aloysius J Klingelhutz; Wilmara Salgado-Pabón
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

3.  A Case Report of Successful Conservative Treatment for Infective Endocarditis Caused by Gemella sanguinis.

Authors:  Georgia Emmanouilidou; Panagiota Voukelatou; Ioannis Vrettos; Vasileia Aftzi; Konstantinos Dodos; Despoina Koumpouli; George Avgeropoulos; Andreas Kalliakmanis
Journal:  Case Rep Infect Dis       Date:  2019-01-02

Review 4.  A narrative review of early surgery versus conventional treatment for infective endocarditis: do we have an answer?

Authors:  Umberto Benedetto; Cristiano Spadaccio; Federico Gentile; Marc R Moon; Francesco Nappi
Journal:  Ann Transl Med       Date:  2020-12

5.  Novel Tissue Level Effects of the Staphylococcus aureus Enterotoxin Gene Cluster Are Essential for Infective Endocarditis.

Authors:  Christopher S Stach; Bao G Vu; Joseph A Merriman; Alfa Herrera; Michael P Cahill; Patrick M Schlievert; Wilmara Salgado-Pabón
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.